BioCentury | Jul 5, 2010
Company News

ProStrakan, Uluru, Crawford Pharmaceuticals deal

...be split equally between the partners. Uluru gained the antibiotic through last year's acquisition of York Pharma plc...
BioCentury | Oct 19, 2009
Finance

Ebb & Flow

...fiscal year ended June 30. Solvay had planned to sell the products last year to York Pharma plc...
BioCentury | Aug 3, 2009
Company News

York Pharma dermatology news

...£28.6 million ($47 million) through the sale of debt and equity (see BioCentury, July 6). York Pharma plc...
BioCentury | Jul 6, 2009
Company News

Uluru, York Pharma deal

...the company had a 12-month operating loss of $10.1 million. Uluru Inc. (NYSE-A:ULU), Addison, Texas York Pharma plc...
BioCentury | Jul 6, 2009
Company News

York Pharma management update

York Pharma plc (LSE:YRK), Milton Keynes, U.K. Business: Dermatology Departing: Terry Sadler, founder and president WIR Staff Dermatology...
BioCentury | Apr 13, 2009
Company News

Uluru, York Pharma deal

...million ($56.6 million) (see BioCentury, Jan. 26, & April 6). Uluru Inc. (NYSE-A:ULU), Addison, Texas York Pharma plc...
BioCentury | Apr 6, 2009
Company News

York Pharma dermatology news

...since raised at least £28.6 million ($56.6 million) (see BioCentury, Jan. 26 and Feb. 9). York Pharma plc...
BioCentury | Feb 9, 2009
Company News

York Pharma dermatology news

...The company has since raised at least £28.6 million ($56.6 million) (see BioCentury, Jan. 26). York Pharma plc...
BioCentury | Jan 26, 2009
Company News

York Pharma, Solvay deal

...raised at least £28.6 million ($56.6 million), excluding the £14.4 million loan facility with Fortress. York Pharma plc...
BioCentury | Jan 5, 2009
Company News

Sinclair, York Pharma sales and marketing update

...plc (LSE:PSK, Galashiels, U.K.) (see BioCentury, Oct. 15, 2007). Sinclair Pharma plc (LSE:SPH), Godalming, U.K. York Pharma plc...
Items per page:
1 - 10 of 34
BioCentury | Jul 5, 2010
Company News

ProStrakan, Uluru, Crawford Pharmaceuticals deal

...be split equally between the partners. Uluru gained the antibiotic through last year's acquisition of York Pharma plc...
BioCentury | Oct 19, 2009
Finance

Ebb & Flow

...fiscal year ended June 30. Solvay had planned to sell the products last year to York Pharma plc...
BioCentury | Aug 3, 2009
Company News

York Pharma dermatology news

...£28.6 million ($47 million) through the sale of debt and equity (see BioCentury, July 6). York Pharma plc...
BioCentury | Jul 6, 2009
Company News

Uluru, York Pharma deal

...the company had a 12-month operating loss of $10.1 million. Uluru Inc. (NYSE-A:ULU), Addison, Texas York Pharma plc...
BioCentury | Jul 6, 2009
Company News

York Pharma management update

York Pharma plc (LSE:YRK), Milton Keynes, U.K. Business: Dermatology Departing: Terry Sadler, founder and president WIR Staff Dermatology...
BioCentury | Apr 13, 2009
Company News

Uluru, York Pharma deal

...million ($56.6 million) (see BioCentury, Jan. 26, & April 6). Uluru Inc. (NYSE-A:ULU), Addison, Texas York Pharma plc...
BioCentury | Apr 6, 2009
Company News

York Pharma dermatology news

...since raised at least £28.6 million ($56.6 million) (see BioCentury, Jan. 26 and Feb. 9). York Pharma plc...
BioCentury | Feb 9, 2009
Company News

York Pharma dermatology news

...The company has since raised at least £28.6 million ($56.6 million) (see BioCentury, Jan. 26). York Pharma plc...
BioCentury | Jan 26, 2009
Company News

York Pharma, Solvay deal

...raised at least £28.6 million ($56.6 million), excluding the £14.4 million loan facility with Fortress. York Pharma plc...
BioCentury | Jan 5, 2009
Company News

Sinclair, York Pharma sales and marketing update

...plc (LSE:PSK, Galashiels, U.K.) (see BioCentury, Oct. 15, 2007). Sinclair Pharma plc (LSE:SPH), Godalming, U.K. York Pharma plc...
Items per page:
1 - 10 of 34